Urologix Targis BPH Procedure Kit Sales Growth Spurs 38% August Stock Gain
This article was originally published in The Gray Sheet
Executive Summary
Increased procedure kit sales for use with Urologix' Targis microwave catheter-based system for treatment of benign prostatic hyperplasia helped give the Minneapolis firm's stock a 38% boost in August.
You may also be interested in...
ArthroCare's Entry Into Spine Surgery Market Attracts Backers To Stock
ArthroCare anticipates pursuing additional spinal applications within the next year for its Coblation-based surgical tools following the firm's recent entry into the European spine surgery market.
Medtronic Entering $450 Mil. ENT Market Via $800 Mil. Xomed Acquisition
Acquisition of surgical ear nose and throat device maker Xomed Surgical Products under an Aug. 27 merger agreement valued at $800 mil. will mark Medtronic's entrance into the $450 mil. worldwide ENT market.
Minimed
Launches Model 407C infusion pump for general medication use following 510(k) clearance June 23. Similar to the firm's insulin infusion pumps and designed to deliver medications suitable for subcutaneous administration, the 407C represents diversification of the firm's technology to include disease states other than diabetes. MiniMed expects the device to be first used in connection with its alliance with United Therapeutics for the treatment of pulmonary hypertension